Atea plunges after COVID-19 treatment fails to help patients in study
Go back to Atea plunges after COVID-19 treatment fails to help patients in study| (NASDAQ: AVIR) | Delayed: 5.43 +0.07 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.36 | 52 Week High | $2.00 | |||
| Open | $5.40 | 52 Week Low | $1.15 | |||
| Day High | $5.64 | P/E | N/A | |||
| Day Low | $5.31 | EPS | $0.00 | |||
| Volume | 209,894 | |||||

